(19) |  |
| (11) | EP 4 218 807 A3 |
(12) | EUROPEAN PATENT APPLICATION |
(88) | Date of publication A3: | | 06.09.2023 Bulletin 2023/36 |
(43) | Date of publication A2: | | 02.08.2023 Bulletin 2023/31 |
(22) | Date of filing: 23.12.2016 |
| (51) | International Patent Classification (IPC): |
|
(84) | Designated Contracting States: | | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
(30) | Priority: | 23.12.2015 EP 15202585 18.03.2016 EP 16161068 23.06.2016 EP 16176025 23.06.2016 EP 16176049 04.08.2016 EP 16182845
|
(62) | Application number of the earlier application in accordance with Art. 76 EPC: | | 16828746.4 / 3393510 |
(71) | Applicant: Valneva Austria GmbH | | 1030 Vienna (AT) |
| (72) | Inventors: | | - BARBERO CALZADO, Jana
Vienna (AT) - NEBENFÜHR, Mario
Vienna (AT) - SCHLEGL, Robert
Siegenfeld (AT) - WEBER, Michael
Vienna (AT) - WRUSS, Jürgen
Vienna (AT)
|
(74) | Representative: Script IP Limited | | Suite J, Anchor House
School Close
Chandlers Ford Eastleigh, Hampshire SO53 4DY Eastleigh, Hampshire SO53 4DY (GB) |
|
| |
(57) Described herein are Zika virus vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.